FdaApplication

ANDA 219323

Back to search

Identifiers

Properties

PropertyValue
applicant_nameALKEM LABORATORIES LTD
application_typeANDA
approval_date2026-01-20

Products (1)

ProductActive ingredientStrengthDosage form
MIRABEGRONMIRABEGRON8MG/MLFOR SUSPENSION, EXTENDED RELEASE;ORAL

1 product